Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Wang, Ting
NCT06000956: A Study of Comparing Overall Improvement of Patients With Spondyloarthritis Treated With Jitongning Tablets and Placebo	Recruiting	3	408	RoW	Jitongning tablets, a simulated agent of Jitongning tablets	Tasly Pharmaceutical Group Co., Ltd	Ankylosing Spondylitis	12/26	12/26
ACNTBC, NCT05558722: Anlotinib Combined With Chemotherapy and Neoadjuvant Therapy for Hormone Receptor-positive HER-2 Negative Breast Cancer	Recruiting	2	30	RoW	Anlotinib, TAC	Xijing Hospital	Breast Cancer Stage II	07/23	07/25